Sophie CLAUDEL,Jeanne STEMMELIN,Pascal BARNEOUD,Philippe DELAY-GOYET,Mathilde LOPEZ-GRANCHA,Jeremy PRATT
申请号：
US15063977
公开号：
US20160256449A1
申请日:
2016.03.08
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The disclosure relates to the compound 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide or a pharmaceutically acceptable salt thereof, intended for the treatment of Alzheimer's disease and other types of dementia.
